Regulation and Welfare : Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry
Year of publication: |
2015
|
---|---|
Authors: | Branstetter, Lee |
Other Persons: | Chatterjee, Chirantan (contributor) ; Higgins, Matthew John (contributor) |
Publisher: |
[2015]: [S.l.] : SSRN |
Subject: | Wohlfahrtsanalyse | Welfare analysis | Markteintritt | Market entry | Generika | Generic drugs | Regulierung | Regulation | Pharmaindustrie | Pharmaceutical industry |
Extent: | 1 Online-Ressource (41 p) |
---|---|
Series: | NBER Working Paper ; No. w17188 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments June 2011 erstellt |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Regulation and welfare : evidence from paragraph IV generic entry in the pharmaceutical industry
Branstetter, Lee, (2016)
-
Regulation and Welfare : Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry
Branstetter, Lee G., (2011)
-
Pay-for-delay patent settlement, generic entry and welfare
Ding, Yucheng, (2019)
- More ...
-
Branstetter, Lee, (2015)
-
Kim, Yujin, (2018)
-
Unpacking the Effects of Adverse Regulatory Events : Evidence from Pharmaceutical Relabeling
Higgins, Matthew John, (2018)
- More ...